Immunomodulatory functions of murine CR1/2

Immunopharmacology

Volumn 49, Issue 1-2, 2000, Pages 117-124

  Prechl, József ^a   Erdei, Anna ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

B cell response; Complement activation; Murine CR1 2; Receptor cross talk

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B RECEPTOR; REELIN;

B LYMPHOCYTE ACTIVATION; COMPLEMENT ACTIVATION; CONFERENCE PAPER; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033947328     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)80297-0     Document Type: Conference Paper

References (59)

1. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:1996;251-262.
2. Arvieux J., Yssel H., Colomb M.G. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology. 65:1988;229-235.
3. Axcrona K., Gray D., Leanderson T. Regulation of B cell growth and differentiation via CD21 and CD40. Eur. J. Immunol. 26:1996;2203-2207.
4. Baiu D.C., Prechl J., Tchorbanov A., Molina H.D., Erdei A., Sulica A., Capel P.J.A., Hazenbos W.L.W. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J. Immunol. 162:1999;3125-3130.
5. Boackle S.A., Holers V.M., Karp D.R. CD21 augments antigen presentation in immune individuals. Eur. J. Immunol. 27:1997;122-130.
6. Boackle S.A., Morris M.A., Holers V.M., Karp D.R. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J. Immunol. 161:1998;6537-6543.
7. Carroll M.C. Role of complement receptors CD21/CD35 in B lymphocyte activation and survival. Curr. Top. Microbiol. Immunol. 246:1999;63-68.
8. Dempsey P.W., Allison M.E.D., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
9. Ember J.A., Hugli T.E. Complement factors and their receptors. Immunopharmacology. 38:1997;3-15.
10. Erdei A., Spaeth E., Alsenz J., Rüde E., Schulz T., Gergely J., Dierich M.P. Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation. Mol. Immunol. 21:1984;1215-1221.
11. Erdei A., Melchers F., Schultz T., Dierich M. The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes. Eur. J. Immunol. 15:1985;184-188.
12. Erdei A., Tóth G.K., Andrásfalvy M., Matkó J., Bene L., Bajtay Zs., Ischenko A., Rong X., Pecht I. Inhibition of IgE-mediated triggering of mast cells by complement-derived peptides interacting with the FcεRI. Immunol. Lett. 68:1999;79-82.
13. Fang Y., Xu C., Fu Y., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:1998;5273-5279.
14. Fearon D.T. The complement system and adaptive immunity. Sem. Immunol. 10:1998;355-361.
15. Feuerstein N., Chen F., Madaio M., Eisenberg R.A. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: Changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins. J. Immunol. 163:1999;5287-5297.
16. Fingeroth J.D., Benedict M.A., Levy D.N., Strominger J.L. Identification of murine complement receptor type 2. Proc. Natl. Acad. Sci. 86:1989;242-246.
17. Fisher M.B., Goerg S., Shen L., Prodeus A.P., Goodnow C.C., Kelsoe G., Carroll M.C. Dependence of germinal centre B cells on expression of CD21-35 for survival. Science. 280:1998;582-585.
18. Gustavsson S., Kinoshita T., Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154:1995;6524-6528.
19. Heyman B. The role of complement receptors in the regulation of the immune response. Erdei A. New Aspects of Complement Structure and Function. 1994;59-72 R.G. Landes, Austin.
20. Hu H., Martin B.K., Weis J.J., Weis J.H. Expression of the murine CD21 gene is regulated by promoter and intronic sequences. J. Immunol. 158:1997;4758-4768.
21. Hsu M.H., Ember J.A., Wang M., Prossnitz E.R., Hugli T.E., Ye R.D. Cloning and functional characterization of the mouse C3a anaphylatoxin receptor gene. Immunogenetics. 47:1997;64-72.
22. Hugli T.E. Structure and function of the anaphylatoxins. Müller-Eberhard H., Miescher P.A. Complement. 1985;Springer, Berlin Heidelberg NY.
23. Kerekes K., Prechl J., Bajtay Zs., Józsi M., Erdei A. A futher link between innate and adaptive immunity: C3 deposition on antigen presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 10:1998;1923-1930.
24. Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to murine complement receptor type 1 (CR1). J. Immunol. 140:1988;3066-3072.
25. Kinoshita T., Thyphronitis G., Tsokos G.C., Finkelman F.D., Hong K., Sakai H., Inoue K. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:1990;651-659.
26. Kozono Y., Duke R.C., Schleicher M.S., Holers V.M. Co-ligation of mouse complement receptors 1 and 2 with surface IgM rescues splenic B cells and WEHI-231 cells from anti-surface IgM induced apoptosis. Eur. J. Immunol. 25:1995;1013-1017.
27. Kozono Y., Abe R., Kozono H., Kelly R.G., Azuma T., Holers V.M. Cross-linking CD21-35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1998;1565-1572.
28. Krop I., Shaffer A.L., Fearon D.T., Schlissel M.S. The signaling activity of murine CD19 is regulated during B cell development. J. Immunol. 157:1996;48-56.
29. Kurtz C.B., O'Tool E., Christensen S.M., Weis J.H. The murine complement receptor gene family(IV). Alternative splicing of Cr2 gene transcripts predicts two distinct products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:1990;3581-3592.
30. Melchers F., Erdei A., Schultz T., Dierich M. Growth control of activated, synchronized murine B cells by the C3d fragment of human complement. Nature. 317:1985;264-265.
31. Molina H., Kinoshita T., Inoue K., Carel J.C., Holers V.M. A molecular and immunochemical characterization of mouse CR2. J. Immunol. 145:1990;2974-2983.
32. Molina H., Kinoshita T., Webster C.B., Holers V.M. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153:1994;789-795.
33. Molina H., Holers V.M., Li B., Fang Y., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., Chaplin D.D. Markedly impaired immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA. 93:1996;3357-3361.
34. Morgan E.L., Weigle W.O., Hugli T.E. Anaphylatoxin-mediated regulation of human and murine immune responses. Fed. Proc. 43:1984;2543-2547.
35. Morris S.C., Lees A., Finkelman F.D. In vivo activation of naive T cells by antigen presenting B cells. J. Immunol. 152:1994;3777-3785.
36. Mousli M., Hugli T.E., Landry Y., Bronner C. Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology. 27:1994;1-9.
37. Nariuchi H., Kakiuchi T., Ueno J. Effect of priming with antigen on the expression of C3 receptors on murine B cells and the responses to TI-2 antigens. J. Immunol. 134:1985;748-753.
38. Ochsenbeim A.F., Pinschewer D.D., Odermatt B., Carrol M.C., Hengartner H., Zinkernagel R.M. Protective T-cell independent antiviral antibody responses are dependent on complement. J. Exp. Med. 190:1999;1165-1174.
39. Pepys M.B. Role of complement in induction of antibody production in vivo. Effect of Cobra Venom Factor and other C3-reactive reagents on thymus-dependent and thymus-independent antibody response. J. Exp. Med. 140:1974;126-145.
40. Pramoonjago P., Takeda J., Kim Y.U., Inoue K., Kinoshita T. Ligand specificities of mouse complement receptor type 1 (CR1) and 2 (CR2) purified from spleen cells. Int. Immunol. 5:1993;337.
41. Prechl J., Tchorbanov A., Horváth A., Baiu D.C., Hazenbos W., Kurucz I., Rajnavölgyi E., Capel P.J.A., Erdei A. Targeting of influenza epitopes to murine CR1/2 single chain antibodies. Immunopharmacology. 42:1999;159-165.
42. Prodeus A., Zhou X., Maurer M., Galli S.J., Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 390:1997;172-175.
43. Prodeus A., Goerg S., Shen L., Pozdnyakova O.O., Chu L., Alicot E.M., Goodnow C.C., Carroll M.C. A critical role for complement in maintanance of self-tolerance. Immunity. 9:1998;721-731.
44. Prodinger W.M., Würzner R., Erdei A., Dierich M.P. Complement. Paul W.E. Fundamental Immunology. 1999;967-995 Lippincott-Raven Publishers, Phialdelphia.
45. Qin D., Wu J., Carroll M.C., Burton G.F., Szakal A.K., Tew J.G. Evidence for an important interaction between a complement derived CD21 ligand on follicular dendritic cells and CD21 on B cels in the initiation of IgG responses. J. Immunol. 161:1998;4549-4554.
46. Roberts T., Snow E.C. Recruitment of the CD19-CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bc1-2 by resting and cycling hen egg lysosyme transgenic B cells. J. Immunol. 162:1999;4377-4380.
47. Rother K. Complement deficiencies in animals: impact on biological functions. Rother K., Till G.O., Hansch G.M. The Complement System. 1998;343-350 Springer Verlag Berlin Heidelberg.
48. Takahashi K., Kozono Y., Waldschmidt T.J., Berthiaume D., Quigg R.J., Baron A., Holers V.M. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2; CD21). Expression on normal B cel subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159:1997;1557-1569.
49. Tedder T.F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6:1997;107-118.
50. Thornton B.P., Vetvicka V., Ross G.D. Natural Antibody and Complement-Mediated Antigen Processing and Presentation by B Lymphocytes. J. Immunol. 152:1994;1727-1737.
51. Thornton B.P., Vetvicka V., Ross G.D. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104:1996;531-537.
52. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J., Tsokos G.C., Metcalf E.S., Finkelman F.D., Balow J.E. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:1991;224-230.
53. Tornetta M.A., Foley J.J., Sarau H.M., Ames R.S. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression. J. Immunol. 158:1997;5277-5282.
54. Tsokos G.C., Kinosgita T., Thyphronitis G., Patel A.D., Dickler H.B., Finkelman F.D. Interactions between murine B lymphocyte surface membrane molecules. Loaded but not free receptors for complement and the Fc portion of IgG co-cap independently with cross-linked surface Ig. J. Immunol. 144:1990;239-243.
55. Tsubata T. Co-receptors on B lymphocytes. Curr. Opinion Immunol. 11:1999;249-255.
56. Venkataraman C., Lu P.-J., Buhl A.M., Chen C.-S., Cambier J.C., Bondada S. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase. Eur. J. Immunol. 28:1998;3003-3016.
57. Villiers M., Villiers C.L., Laharie A., Marche P.N. Amplification of the antibody response by C3b complexed to antigen through an ester link. J. Immunol. 162:1999;3647-3652.
58. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., Carrol M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. 92:1995;11490-11494.
59. Zabel M.D., Weis J.J., Weis J.H. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. J. Immunol. 163:1999;2697-2703.